Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Koch

Showing results (291-300 of 296) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 296 results.
The Journal of Urology|May 24, 2024
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical TrialClinton D Bahler, Isamu Tachibana, Mark Tann, et al.
Scandinavian Journal of Urology|May 14, 2020
Robotic and open partial nephrectomy for intermediate and high complexity tumors: a matched-pairs comparison of surgical outcomes at a single institutionZain A Abedali, M Francesca Monn, Patrick Huddleston, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant ChemotherapyDerek E Thomas, Hristos Z Kaimakliotis, Kevin R Rice, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Pageof 30

Showing results (291-300 of 296) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 296 results.
The Journal of Urology|May 24, 2024
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical TrialClinton D Bahler, Isamu Tachibana, Mark Tann, et al.
Scandinavian Journal of Urology|May 14, 2020
Robotic and open partial nephrectomy for intermediate and high complexity tumors: a matched-pairs comparison of surgical outcomes at a single institutionZain A Abedali, M Francesca Monn, Patrick Huddleston, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant ChemotherapyDerek E Thomas, Hristos Z Kaimakliotis, Kevin R Rice, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Pageof 30